BeOne Medicines AG
ONC
$335.17
$2.460.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 80.73M | -165.46M | -380.18M | -632.60M | -827.70M |
| Total Depreciation and Amortization | 264.28M | 298.64M | 292.52M | 285.00M | 201.91M |
| Total Amortization of Deferred Charges | 13.19M | 12.84M | 8.27M | 8.28M | 7.29M |
| Total Other Non-Cash Items | 593.47M | 561.02M | 546.01M | 530.62M | 515.87M |
| Change in Net Operating Assets | -129.82M | -99.37M | -218.14M | -295.47M | -508.84M |
| Cash from Operations | 821.84M | 607.66M | 248.47M | -104.18M | -611.48M |
| Capital Expenditure | -236.08M | -321.65M | -387.77M | -487.95M | -525.32M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -249.06M | -248.09M | -226.40M | -214.11M | -267.58M |
| Cash from Investing | -485.14M | -569.74M | -614.17M | -702.06M | -792.89M |
| Total Debt Issued | 770.10M | 770.10M | 810.96M | 882.04M | 833.88M |
| Total Debt Repaid | -855.63M | -854.92M | -907.41M | -733.85M | -329.73M |
| Issuance of Common Stock | 180.89M | 116.58M | 89.00M | 40.43M | 37.73M |
| Repurchase of Common Stock | -24.20M | -24.20M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -14.49M | -14.49M | -14.49M | -14.49M |
| Other Financing Activities | 907.20M | 22.20M | 25.20M | 25.20M | 21.35M |
| Cash from Financing | 992.57M | 43.96M | 31.95M | 228.02M | 579.11M |
| Foreign Exchange rate Adjustments | -13.13M | 5.31M | -24.07M | -49.98M | -14.27M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.32B | 87.19M | -357.81M | -628.20M | -839.53M |